YILMAZ ORAL, D. Et Al. 2017. The Beneficial Effect of Fesoterodine, a Competitive Muscarinic Receptor Antagonist on Erectile Dysfunction in Streptozotocin-induced Diabetic Rats. UROLOGY , vol.107 .

YILMAZ ORAL, D., Bayatli, N., & GÜR, S., (2017). The Beneficial Effect of Fesoterodine, a Competitive Muscarinic Receptor Antagonist on Erectile Dysfunction in Streptozotocin-induced Diabetic Rats. UROLOGY , vol.107.

YILMAZ ORAL, DİDEM, Nur Bayatli, And SERAP GÜR. "The Beneficial Effect of Fesoterodine, a Competitive Muscarinic Receptor Antagonist on Erectile Dysfunction in Streptozotocin-induced Diabetic Rats," UROLOGY , vol.107, 2017

YILMAZ ORAL, DİDEM Y. Et Al. "The Beneficial Effect of Fesoterodine, a Competitive Muscarinic Receptor Antagonist on Erectile Dysfunction in Streptozotocin-induced Diabetic Rats." UROLOGY , vol.107, 2017

YILMAZ ORAL, D. Bayatli, N. And GÜR, S. (2017) . "The Beneficial Effect of Fesoterodine, a Competitive Muscarinic Receptor Antagonist on Erectile Dysfunction in Streptozotocin-induced Diabetic Rats." UROLOGY , vol.107.

@article{article, author={DİDEM YILMAZ ORAL Et Al. }, title={The Beneficial Effect of Fesoterodine, a Competitive Muscarinic Receptor Antagonist on Erectile Dysfunction in Streptozotocin-induced Diabetic Rats}, journal={UROLOGY}, year=2017}